OXIS International Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.”
Their products include therapeutic nutraceutical products, cosmeceutical products and proprietary formulations and clinical products that are developed internally and/or out-licensed to biotech and pharmaceutical companies as drug candidates.
They focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-Ergothioneine (“ERGO”), as a key component. They own several patents and pending applications related to ERGO that cover current and planned products relevant to their nutraceutical and cosmecuetical businesses. Their patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process.
OXIS’ consumer products strategy addresses very important health concerns including aging and age-related disorders that are increasing with trends in US demographics. These concerns include:
- Brain health
- Immunity against diseases
- Anti-aging/skin health
- Inflammation
- Detoxification
- Blood sugar regulation
You can follow Oxis on facebook and you can found out more of them and how Oxis can help you.